| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.7M | +1.7% | -24.8% |
| R&D Expense | $25.3M | +12.3% | -3.7% |
| SG&A Expense | $6.2M | -11.1% | -18.7% |
| Operating Income | -$22.8M | -8.8% | -2.0% |
| Pre-tax Income | -$20.6M | -3.8% | +1.2% |
| Income Tax | -$234K | -631.8% | +88.9% |
| Net Income | -$20.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $32.8M | +22.1% | +30.5% |
| Accounts Receivable | $960K | +6.7% | +63.0% |
| Current Assets | $189.8M | -10.3% | -32.8% |
| Total Assets | $247.9M | -8.9% | -30.8% |
| Current Liabilities | $29.6M | -11.1% | -35.3% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$65.3M | — | — |
| Capital Expenditures | $489K | — | — |
| Investing Cash Flow | $71.2M | — | — |
| Financing Cash Flow | -$430K | — | — |
| Free Cash Flow | -$65.8M | — | — |
| -2.4% |
| -8.6% |
| EPS (Basic) | -$0.55 | -1.9% | -7.8% |
| EPS (Diluted) | -$0.55 | -1.9% | -7.8% |
| $69.5M |
| -9.1% |
| -32.3% |
| Stockholders' Equity | $178.4M | -8.9% | -30.2% |